Cancer

Title Average Ratingsort descending
Combined therapy with Ukrain and chemotherapy in ovarian cancer (case report) 60.00%
Theoretical grounds and experimental confirmation of the antiviral effect of the 60.00%
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary stu 60.00%
Low-dose methotrexate and cyclophosphamide in recurrent ovarian cancer. 60.00%
Review. Current role and future perspectives of hyperthermia for prostate cancer treatment. 60.00%
Clinical management of adrenocortical carcinoma 60.00%
Antiangiogenic drugs currently used for colorectal cancer: what other pathways can we target to prolong responses? 60.00%
Ukrain treatment in carcinoma of the cervix (case report) 60.00%
Nuts and green tea key to cancer treatment? 60.00%
Clinical studies of Ukrain in healthy volunteers (phase 1). 60.00%
Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis. 60.00%
Immunostimulatory effects of low-dose cyclophosphamide are controlled by inducible nitric oxide synthase. 60.00%
Significance of thymidine phosphorylase in metronomic chemotherapy using CPT-11 and doxifluridine for advanced colorectal...... 60.00%
Is there a role for herbal medicine in the treatment of pancreatic cancer?. Highlights from the "44th ASCO Annual Meeting". 60.00%
Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary 60.00%
Ukrain therapy of stage T1N0M0 bladder cancer patients 60.00%
Biophysiological effects of Ukrain therapy in a patient with breast cancer (case report) 60.00%
Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo 60.00%
Enhanced proliferation and potassium conductance of Schwann cells isolated from NF2 schwannomas can be reduced by quinidine. 60.00%
Hypoxia-inducible factor-1alpha modulation in combination with anti-angiogenic therapy. 60.00%
Cancer mortality in six lowest versus six highest elevation jurisdictions in the u.s. 60.00%
Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symp 60.00%
N-Acetylcysteine: Multiple Clinical Applications 60.00%
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glyc 60.00%
Update on pilot study on antitumor efficacy of intravenously applied synergistic combinations of diflunisal, PAS, and aspirin in patients with advanced solid tumors. 60.00%
Anti-Cancer Infusions 60.00%
A phase II clinical trial of sorafenib in androgen-independent prostate cancer. 60.00%
The Result of Vitamin C Treatment of Patients with Cancer: Conditions Influencing the Effectiveness 60.00%
Programmed drug delivery: nanosystems for tumor targeting. 60.00%
Multicenter phase II study of temozolomide therapy for brain metastasis in patients with malignant melanoma, breast cancer...... 60.00%
Oncolytic virus therapy for malignant brain tumors 60.00%
Cysteine proteinases and their inhibitors in the development of mouse HA-1 hepatoma and antineoplastic therapy 60.00%
Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. 60.00%
Metronomic administration of ibandronate and its anti-angiogenic effects in vitro. 60.00%
Ukrain both as an anti cancer and immunoregulatory agent 60.00%
Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer with metronomic UFT + CP 60.00%
Review on molecular and therapeutic potential of thymoquinone in cancer. 60.00%
Ukrain 62.22%
Chelidonium majus L. (Ukrain) in the treatment of cancer patients. 63.33%
Evaluation of Ukrain as an immunostimulant in patients with various carcinomas. 63.33%
Dose-Dense and/or Metronomic Schedules of Specific Chemotherapies Consolidate the Chemosensitivity of Triple-Negative Breast Can 63.33%
Animal studies on Ukrain 65.00%
Albarin, Injectable Aloe Vera or Polymannons 65.00%
Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. 65.00%
Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. 70.00%
Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. 70.00%
Gastric cancer originating from bone marrow-derived cells. 70.00%
Oncolytic Virus Treatment 70.00%
Photodynamic Therapy 70.00%
Durable responses with the antiangiogenic metronomic regimen RT-PEPC in elderly patients with recurrent mantle cell lymphoma 70.00%
Phase II trial of pharmacodynamically (PDally)-guided optimal biologic dose titration (OBDT) of sorafenib (S) in combination wit 70.00%
A phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination.............. 70.00%
Clinical-translational strategies for the elevation of Nm23-H1 metastasis suppressor gene expression. 70.00%
Anticancer Effect of Dihydroartemisinin (DHA) in a Pancreatic Tumor Model Evaluated by Conventional Methods and Optical Imaging. 70.00%
In vitro induction of apoptotic cell death in chronic lymphocytic leukemia by two natural products: preliminary study 70.00%
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-indep.. 70.00%
Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. 70.00%
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo 70.00%
Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer 70.00%
Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives. 70.00%
Ukrain treatment in carcinoma of the oesophagus (case report) 70.00%
Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemi 70.00%
Controlled clinical evaluations of chlorine dioxide, chlorite and chlorate in man. 70.00%
Experimental Radiology 70.00%
Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications. 70.00%
SONIA POULTON INTERVIEWS DR. MIKAEL NORDFORS CORRUPTED MEDICINE AND ALTERNATIVE TREATMENTS. 70.00%
Cancer preventive effect of Morinda citrifolia (Noni). 70.00%
Effects of opioids on the immune system. 70.00%
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide r 70.00%
Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy. 70.00%
Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119 70.00%
Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer. 70.00%
Brain tumour cells killed by anti-nausea drug 70.00%
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer 70.00%
Effect of culture supernatant of Toxoplasma gondii on the proliferation and apoptosis of BGC-823 cells 70.00%
Proton Therapy 70.00%
The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline 70.00%
Milk consumption is a risk factor for prostate cancer in Western countries: evidence from cohort studies. 70.00%
Cancer Growth and Its Inhibition in Terms of Coherence 70.00%
Efficacy of ukrain in the treatment of pancreatic cancer. 70.00%
BET bromodomain inhibition as a therapeutic strategy to target c-Myc 70.00%
Phase I study of sunitinib malate continuously dosed and standard-infusion gemcitabine in solid tumors. 70.00%
Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model. 70.00%
Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. 70.00%
Oncologic benefit of tonsillectomy in stage I and II tonsil cancer: a surveillance epidemiology and end results database review 70.00%
Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines 70.00%
Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells. 70.00%
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm). 70.00%
Cyberknife 70.00%
High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and re 70.00%
A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses 70.00%
Oireachtas Special Committee on COVID-19 Response 70.00%
PPAR gamma agonists can be expected to potentiate the efficacy of metronomic chemotherapy through CD36 up-regulation. 70.00%
Randomized phase II trial of capecitabine versus capecitabine, low molecular weight heparin, and prednisone in refractory....... 70.00%
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer. 70.00%
Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts. 70.00%
Digitoxin and its analogs as novel cancer therapeutics. 70.00%
New techniques in radiation therapy for head and neck cancer: IMRT, CyberKnife, protons, and carbon ions. Improved effectiveness and safety? Impact on survival? 70.00%
Continuous oral capecitabine at fixed dose in patients older than 75 years with metastatic colorectal and gastric cancer: a stu 70.00%
Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal ca. patients 70.00%

Pages